These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

437 related items for PubMed ID: 26638886

  • 1. S-equol, a Secondary Metabolite of Natural Anticancer Isoflavone Daidzein, Inhibits Prostate Cancer Growth In Vitro and In Vivo, Though Activating the Akt/FOXO3a Pathway.
    Lu Z, Zhou R, Kong Y, Wang J, Xia W, Guo J, Liu J, Sun H, Liu K, Yang J, Mi M, Xu H.
    Curr Cancer Drug Targets; 2016; 16(5):455-65. PubMed ID: 26638886
    [Abstract] [Full Text] [Related]

  • 2. Platycodin D induces tumor growth arrest by activating FOXO3a expression in prostate cancer in vitro and in vivo.
    Zhou R, Lu Z, Liu K, Guo J, Liu J, Zhou Y, Yang J, Mi M, Xu H.
    Curr Cancer Drug Targets; 2015; 14(9):860-71. PubMed ID: 25431082
    [Abstract] [Full Text] [Related]

  • 3. T63, a new 4-arylidene curcumin analogue, induces cell cycle arrest and apoptosis through activation of the reactive oxygen species-FOXO3a pathway in lung cancer cells.
    Liu H, Zhou BH, Qiu X, Wang HS, Zhang F, Fang R, Wang XF, Cai SH, Du J, Bu XZ.
    Free Radic Biol Med; 2012 Dec 15; 53(12):2204-17. PubMed ID: 23085518
    [Abstract] [Full Text] [Related]

  • 4. Regulation of Akt/FOXO3a/GSK-3beta/AR signaling network by isoflavone in prostate cancer cells.
    Li Y, Wang Z, Kong D, Li R, Sarkar SH, Sarkar FH.
    J Biol Chem; 2008 Oct 10; 283(41):27707-27716. PubMed ID: 18687691
    [Abstract] [Full Text] [Related]

  • 5. Histone Deacetylase (HDAC) Inhibitor, Suberoylanilide Hydroxamic Acid (SAHA), Induces Apoptosis in Prostate Cancer Cell Lines via the Akt/FOXO3a Signaling Pathway.
    Shi XY, Ding W, Li TQ, Zhang YX, Zhao SC.
    Med Sci Monit; 2017 Dec 06; 23():5793-5802. PubMed ID: 29211704
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of AKT promotes FOXO3a-dependent apoptosis in prostate cancer.
    Das TP, Suman S, Alatassi H, Ankem MK, Damodaran C.
    Cell Death Dis; 2016 Feb 25; 7(2):e2111. PubMed ID: 26913603
    [Abstract] [Full Text] [Related]

  • 7. Equol inhibits proliferation of human gastric carcinoma cells via modulating Akt pathway.
    Yang ZP, Zhao Y, Huang F, Chen J, Yao YH, Li J, Wu XN.
    World J Gastroenterol; 2015 Sep 28; 21(36):10385-99. PubMed ID: 26420965
    [Abstract] [Full Text] [Related]

  • 8. Shikonin induces apoptosis of lung cancer cells via activation of FOXO3a/EGR1/SIRT1 signaling antagonized by p300.
    Jeung YJ, Kim HG, Ahn J, Lee HJ, Lee SB, Won M, Jung CR, Im JY, Kim BK, Park SK, Son MJ, Chung KS.
    Biochim Biophys Acta; 2016 Nov 28; 1863(11):2584-2593. PubMed ID: 27452907
    [Abstract] [Full Text] [Related]

  • 9. Regulation of Akt/FoxO3a/Skp2 Axis Is Critically Involved in Berberine-Induced Cell Cycle Arrest in Hepatocellular Carcinoma Cells.
    Li F, Dong X, Lin P, Jiang J.
    Int J Mol Sci; 2018 Jan 23; 19(2):. PubMed ID: 29360760
    [Abstract] [Full Text] [Related]

  • 10. Harmine Hydrochloride Mediates the Induction of G2/M Cell Cycle Arrest in Breast Cancer Cells by Regulating the MAPKs and AKT/FOXO3a Signaling Pathways.
    Ock CW, Kim GD.
    Molecules; 2021 Nov 05; 26(21):. PubMed ID: 34771123
    [Abstract] [Full Text] [Related]

  • 11. Dracorhodin perchlorate induces apoptosis and G2/M cell cycle arrest in human esophageal squamous cell carcinoma through inhibition of the JAK2/STAT3 and AKT/FOXO3a pathways.
    Lu Z, Lu C, Li C, Jiao Y, Li Y, Zhang G.
    Mol Med Rep; 2019 Sep 05; 20(3):2091-2100. PubMed ID: 31322237
    [Abstract] [Full Text] [Related]

  • 12. FOXO3a reactivation mediates the synergistic cytotoxic effects of rapamycin and cisplatin in oral squamous cell carcinoma cells.
    Fang L, Wang H, Zhou L, Yu D.
    Toxicol Appl Pharmacol; 2011 Feb 15; 251(1):8-15. PubMed ID: 21092744
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of the anticancer and anti-metastasis effects of novel synthetic sodium channel blockers in prostate cancer cells in vitro and in vivo.
    Wang J, Lu Z, Wu C, Li Y, Kong Y, Zhou R, Shi K, Guo J, Li N, Liu J, Song W, Wang H, Zhu M, Xu H.
    Prostate; 2019 Jan 15; 79(1):62-72. PubMed ID: 30242862
    [Abstract] [Full Text] [Related]

  • 14. Magnolin inhibits prostate cancer cell growth in vitro and in vivo.
    Huang Y, Zou X, Zhang X, Wang F, Zhu W, Zhang G, Xiao J, Chen M.
    Biomed Pharmacother; 2017 Mar 15; 87():714-720. PubMed ID: 28092770
    [Abstract] [Full Text] [Related]

  • 15. Forkhead Box Transcription Factor (FOXO3a) mediates the cytotoxic effect of vernodalin in vitro and inhibits the breast tumor growth in vivo.
    Ananda Sadagopan SK, Mohebali N, Looi CY, Hasanpourghadi M, Pandurangan AK, Arya A, Karimian H, Mustafa MR.
    J Exp Clin Cancer Res; 2015 Dec 08; 34():147. PubMed ID: 26643256
    [Abstract] [Full Text] [Related]

  • 16. RY-2f, an isoflavone analog, overcomes cisplatin resistance to inhibit ovarian tumorigenesis via targeting the PI3K/AKT/mTOR signaling pathway.
    Liu M, Qi Z, Liu B, Ren Y, Li H, Yang G, Zhang Q.
    Oncotarget; 2015 Sep 22; 6(28):25281-94. PubMed ID: 26325371
    [Abstract] [Full Text] [Related]

  • 17. Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway.
    Shukla S, Bhaskaran N, Babcook MA, Fu P, Maclennan GT, Gupta S.
    Carcinogenesis; 2014 Feb 22; 35(2):452-60. PubMed ID: 24067903
    [Abstract] [Full Text] [Related]

  • 18. Mycotoxin verrucarin A inhibits proliferation and induces apoptosis in prostate cancer cells by inhibiting prosurvival Akt/NF-kB/mTOR signaling.
    Liu Y, Gao X, Deeb D, Zhang Y, Shaw J, Valeriote FA, Gautam SC.
    J Exp Ther Oncol; 2016 Nov 22; 11(4):251-260. PubMed ID: 27849335
    [Abstract] [Full Text] [Related]

  • 19. Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro.
    Hedlund TE, Johannes WU, Miller GJ.
    Prostate; 2003 Jan 01; 54(1):68-78. PubMed ID: 12481257
    [Abstract] [Full Text] [Related]

  • 20. A concentrated aglycone isoflavone preparation (GCP) that demonstrates potent anti-prostate cancer activity in vitro and in vivo.
    Bemis DL, Capodice JL, Desai M, Buttyan R, Katz AE.
    Clin Cancer Res; 2004 Aug 01; 10(15):5282-92. PubMed ID: 15297432
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.